Visugromab

6 trials 4 recruiting

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

4 Recruiting

2 Completed trials

1 Sponsors

11 Countries

Phase II/III

Phase II

Phase I/II

Phase II/III: 1 Phase II: 4 Phase I/II: 1

Indications tested

Bladder cancer 1

Sponsors using this IMP

All trials

6 total

Visugromab in Cachexia International Trial Recruiting

2025-523533-25-00 Phase II/III 11 countries CatalYm GmbH
Visugromab, nivolumab and lenvatinib compared to double placebo and lenvatinib in unresectable or metastatic hepatocellular carcinoma post a… Recruiting

2025-520675-86-00 Phase II 4 countries CatalYm GmbH
A phase 2 placebo-controlled trial to investigate visugromab in combination with immunochemotherapy (ICT) in first-line treatment of partici… Recruiting

2024-516792-32-01 Phase II 6 countries CatalYm GmbH
A phase 2 placebo-controlled trial to investigate visugromab and nivolumab with or without docetaxel in second-line treatment of participant… Recruiting

2024-516794-70-00 Phase II 5 countries CatalYm GmbH
A multi-center Phase 2 study of neoadjuvant immunotherapy in combination with the anti-GDF-15 antibody visugromab (CTL-002) for the treatmen… Ended

2024-513957-55-00 Phase II 1 country CatalYm GmbH
A Phase 1/2, first-in-human, two-part, open-label clinical trial of intravenous administration of CTL-002 given as monotherapy and/or in com… Ended

2024-512575-12-00 Phase I/II 2 countries CatalYm GmbH

Showing 1–6 of 6 trials

← All drugs A–Z